US Bancorp’s Albany Molecular Research Inc AMRI Stock Holding History

US Bancorp’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-5,405	Closed	-$75K	–	3691
2017 Q1	$75K	Buy	5,405 +128	+2%	+$2.1K	﹤0.01%	2282
2016 Q4	$99K	Sell	5,277 -7,963	-60%	-$135K	﹤0.01%	2123
2016 Q3	$219K	Buy	13,240 +8,590	+185%	+$127K	﹤0.01%	1717
2016 Q2	$62K	Hold	4,650	–	–	﹤0.01%	2295
2016 Q1	$71K	Hold	4,650	–	–	﹤0.01%	2203
2015 Q4	$92K	Hold	4,650	–	–	﹤0.01%	2125
2015 Q3	$81K	Hold	4,650	–	–	﹤0.01%	2200
2015 Q2	$94K	Hold	4,650	–	–	﹤0.01%	2186
2015 Q1	$82K	Buy	4,650 +1,500	+48%	+$25.6K	﹤0.01%	2283
2014 Q4	$51K	Hold	3,150	–	–	﹤0.01%	2526
2014 Q3	$70K	Hold	3,150	–	–	﹤0.01%	2309
2014 Q2	$63K	Buy	+3,150	New	+$53.4K	﹤0.01%	2380
2014 Q1	–	Sell	-11,618	Closed	-$117K	–	3596
2013 Q4	$117K	Sell	11,618 -255	-2%	-$3.08K	﹤0.01%	2014
2013 Q3	$153K	Hold	11,873	–	–	﹤0.01%	1824
2013 Q2	$141K	Buy	+11,873	New	+$129K	﹤0.01%	1827

Other funds holding AMRI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CCM

Chicago Capital Management Chicago, Illinois $121M AUM 74.36% 1-Year Est. Return

EWM

Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

US Bancorp's AMRI Position: Q2 2017 in Review

US Bancorp sold out of Albany Molecular Research Inc (AMRI) in Q2 2017, closing a stake of 5,405 shares — an estimated $75K sold.

US Bancorp first reported a position in AMRI in Q2 2013 and held it in 15 quarters. The position peaked at $219K in Q3 2016. 136 funds tracked by Wall St. Rank hold AMRI as of Q2 2017.

US Bancorp reported no remaining Albany Molecular Research Inc position as of Q2 2017 after selling out during the quarter.
US Bancorp sold 5,405 Albany Molecular Research Inc shares in Q2 2017, an estimated $75K.
US Bancorp first reported a position in Albany Molecular Research Inc in Q2 2013 and held it in 15 quarters.
US Bancorp's Albany Molecular Research Inc position peaked at $219K in Q3 2016.
136 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q2 2017.

Based on US Bancorp's 13F filing for Q2 2017, filed 20 Jul 2017.